title: Does a patient qualify for liver transplantation after the down-staging of hepatocellular carcinoma?
authors.affiliation: University of California San Francisco, San Francisco, CA 94143-0538, USA. francis.yao@ucsf.edu
authors.forename: Francis Y
authors.initials: FY
authors.lastname: Yao
authors.forename: Stefan
authors.initials: S
authors.lastname: Breitenstein
authors.forename: Christoph E
authors.initials: CE
authors.lastname: Broelsch
authors.forename: Jean-Francois
authors.initials: JF
authors.lastname: Dufour
authors.forename: Morris
authors.initials: M
authors.lastname: Sherman
mesh_terms: D006528:Carcinoma, Hepatocellular / Q000175:diagnosis / Q000473:pathology / Q000601:surgery / Q000628:therapy*; D019317:Evidence-Based Medicine; D006305:Health Status Indicators; D006801:Humans; D008113:Liver Neoplasms / Q000175:diagnosis / Q000473:pathology / Q000601:surgery / Q000628:therapy*; D016031:Liver Transplantation; D020360:Neoadjuvant Therapy; D009367:Neoplasm Staging; D018579:Patient Selection; D017410:Practice Guidelines as Topic; D011237:Predictive Value of Tests; D016896:Treatment Outcome; D014850:Waiting Lists